Virtual AML Round Table with MD Anderson on October 8th
Event Description
This event will take place at 9 AM PACIFIC, 10 AM MOUNTAIN, 11 AM CENTRAL & 12 NOON EASTERN
Our agenda will cover the following topics:
The MD Anderson Treatment Approach To:
• Treatment in Younger and Older Patients
• Maintenance Therapy
• Evaluating MRD Status
• Stem Cell Transplantation
• New and Emerging Therapies
• Supportive Care During Treatment
MD Anderson AML expert panel:
- Naval Daver, MD - Director, Department of Leukemia
- Nicholas Short, MD - Assistant Professor, Department of Leukemia
- Tapan Kadia, MD - Assistant Professor, Department of Leukemia
- Betul Oran, MD - Associate Professor, Department of Stem Cell Transplantation
- Samantha Salvatora, PA-C - Physician Assistant, Department of Leukemia
- Alexa Probst, MS, PA-C - Supervisor, Advanced Practice Providers, Department of Leukemia
Thank You To Our Round Table Sponsors:
What are HealthTree Round Tables for AML?
These events are education programs for AML patients and caregivers on a variety of treatment and research issues. Each Round Table features presentations from internationally-recognized AML experts who will also participate in extensive Q&A time with audience members. In 2022, these events will take place either in-person at a variety of US-based locations or virtually.
Schedule & Agenda
Speakers & Moderators
Hematologist Oncologist, Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center
Hematologist Oncologist, Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center
Professor in the Department of Stem Cell Transplantation at The University of Texas MD Anderson Cancer Center
Dr. Naval Daver is an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center at the University of Texas. He completed his medical school from Grant Medical College and Sir J group of Hospitals Mumbai, followed by a residency and fellowship in hematology-oncology from Baylor College of Medicine. He is a clinical investigator with a focus on molecular and immune therapies in AML and Myelofibrosis and is principal investigator on over 25 ongoing institutional, national and international clinical trials in these diseases. He is especially interested in developing monoclonal and bispecific antibodies, immune checkpoint and vaccine based approaches in AML, MDS, and myelofibrosis and is leading a number of these trials at MD Anderson Cancer Center.
Physician Assistant, Department of Leukemia at MD Anderson Cancer Center at the University of Texas
Supervisor, Advanced Practice Providers - Department of Leukemia at MD Anderson Cancer Center at the University of Texas
Kerith joined HealthTree Foundation as a Community Co-Director for AML in 2022. She is a mother to a spirited eight-year-old daughter, Adair, and their beloved rescue, Violet. She lost her best friend and husband, Rob, to AML in March 2018. Kerith wishes she had a resource such as HealthTree for AML during Rob’s illness. She is a strong supporter of HealthTree's mission. She hopes that by sharing her experience, she may help other patients and caregivers navigate an AML diagnosis.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
Get the latest thought leadership on your Leukemia delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.